Zimel H, Mogos I, Maltezeanu G
Neoplasma. 1977;24(5):553-7.
Administration of Stilbostat to postmenopasual women with advanced breast cancer markedly improved the clinical state in about 65% of the cases and concomitantly decreased the cutaneous thermic values at the level of the lesions showing a tendency to equalize the values recorded for the symmetrical healthy cutaneous zones. The thermographic test is proposed as a means of estimating the Stilbostat treatment efficiency in breast cancer.
给患有晚期乳腺癌的绝经后女性使用司替勃龙，约65%的病例临床状况明显改善，同时病变部位的皮肤温度值降低，呈现出与对称健康皮肤区域记录值趋于相等的趋势。热成像检查被提议作为评估司替勃龙治疗乳腺癌疗效的一种方法。
